EUVIMEDEUVIMED entdecken
Crossref

RNA interference, an emerging component of antiviral immunity in mammals

Dario Pasquale Anobile, Enzo Z Poirier iD

Biochemical Society Transactions · 2023

DOI: 10.1042/bst20220385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Society Transactions, 2023. Verfasst von Dario Pasquale Anobile und 1 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Immunity Team, Institut Curie, PSL Research University, INSERM U932, Paris, France. Hauptthemen laut MEDLINE: Viruses. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiviral RNA interference (RNAi) is an immune pathway that can, in certain conditions, protect mammalian cells against RNA viruses. It depends on the recognition and dicing of viral double-stranded RNA by a protein of the Dicer family, which leads to the production of viral small interfering RNAs (vsiRNAs) that sequence-specifically guide the degradation of cognate viral RNA. If the first line of defence against viruses relies on type-I and type-III interferons (IFN) in mammals, certain cell types such as stem cells, that are hyporesponsive for IFN, instead use antiviral RNAi via the expression of a specific antiviral Dicer. In certain conditions, antiviral RNAi can also contribute to the protection of differentiated cells. Indeed, abundant vsiRNAs are detected in infected cells and efficiently guide the degradation of viral RNA, especially in cells infected with viruses disabled for viral suppressors of RNAi (VSRs), which are virally encoded blockers of antiviral RNAi. The existence and importance of antiviral RNAi in differentiated cells has however been debated in the field, because data document mutual inhibition between IFN and antiviral RNAi. Recent developments include the engineering of a small molecule inhibitor of VSR to probe antiviral RNAi in vivo, as well as the detection of vsiRNAs inside extracellular vesicles in the serum of infected mice. It suggests that using more complex, in vivo models could allow to unravel the contribution of antiviral RNAi to immunity at the host level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VirusesAnimalsMiceRNA InterferenceRNA, Small InterferingRNA, ViralMammals

Stichwörter der Autor:innen

RNA interferenceinnate immunityvirology

Substanzen

RNA, Small InterferingRNA, Viral

Autor:innen und Institutionen

  • Stem Cell Immunity Team, Institut Curie, PSL Research University, INSERM U932, Paris, France.

ORCID-Profile: Enzo Z Poirier

Zitieren

APA

Anobile, D. P., & Poirier, E. Z. (2023). RNA interference, an emerging component of antiviral immunity in mammals. Biochemical Society Transactions. https://doi.org/10.1042/bst20220385

Vancouver

Anobile DP, Poirier EZ. RNA interference, an emerging component of antiviral immunity in mammals. Biochemical Society Transactions. 2023. doi:10.1042/bst20220385

BibTeX
@article{Anobile2023,
  author = {Anobile, Dario Pasquale and Poirier, Enzo Z},
  title = {RNA interference, an emerging component of antiviral immunity in mammals},
  journal = {Biochemical Society Transactions},
  year = {2023},
  doi = {10.1042/bst20220385}
}
Kostenlos starten →